These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 18507837)
1. Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort. Azzato EM; Driver KE; Lesueur F; Shah M; Greenberg D; Easton DF; Teschendorff AE; Caldas C; Caporaso NE; Pharoah PD Breast Cancer Res; 2008; 10(3):R47. PubMed ID: 18507837 [TBL] [Abstract][Full Text] [Related]
2. Effects of common germ-line genetic variation in cell cycle genes on ovarian cancer survival. Song H; Hogdall E; Ramus SJ; Dicioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Kjaer SK; Pharoah PD; Gayther SA Clin Cancer Res; 2008 Feb; 14(4):1090-5. PubMed ID: 18281541 [TBL] [Abstract][Full Text] [Related]
3. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population. Driver KE; Song H; Lesueur F; Ahmed S; Barbosa-Morais NL; Tyrer JP; Ponder BA; Easton DF; Pharoah PD; Dunning AM; Carcinogenesis; 2008 Feb; 29(2):333-41. PubMed ID: 18174243 [TBL] [Abstract][Full Text] [Related]
6. Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. Goode EL; Fridley BL; Vierkant RA; Cunningham JM; Phelan CM; Anderson S; Rider DN; White KL; Pankratz VS; Song H; Hogdall E; Kjaer SK; Whittemore AS; DiCioccio R; Ramus SJ; Gayther SA; Schildkraut JM; Pharaoh PP; Sellers TA Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):935-44. PubMed ID: 19258477 [TBL] [Abstract][Full Text] [Related]
7. Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer. Udler M; Maia AT; Cebrian A; Brown C; Greenberg D; Shah M; Caldas C; Dunning A; Easton D; Ponder B; Pharoah P J Clin Oncol; 2007 Jul; 25(21):3015-23. PubMed ID: 17634480 [TBL] [Abstract][Full Text] [Related]
8. Potentially functional polymorphisms in cell cycle genes and the survival of non-small cell lung cancer in a Chinese population. Ma H; Chen J; Pan S; Dai J; Jin G; Hu Z; Shen H; Shu Y Lung Cancer; 2011 Jul; 73(1):32-7. PubMed ID: 21145615 [TBL] [Abstract][Full Text] [Related]
9. Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer. Udler MS; Azzato EM; Healey CS; Ahmed S; Pooley KA; Greenberg D; Shah M; Teschendorff AE; Caldas C; Dunning AM; Ostrander EA; Caporaso NE; Easton D; Pharoah PD Int J Cancer; 2009 Dec; 125(11):2687-96. PubMed ID: 19551860 [TBL] [Abstract][Full Text] [Related]
10. Effect of germ-line genetic variation on breast cancer survival in a population-based study. Goode EL; Dunning AM; Kuschel B; Healey CS; Day NE; Ponder BA; Easton DF; Pharoah PP Cancer Res; 2002 Jun; 62(11):3052-7. PubMed ID: 12036913 [TBL] [Abstract][Full Text] [Related]
11. Variant genotypes of CDKN1A and CDKN1B are associated with an increased risk of breast cancer in Chinese women. Ma H; Jin G; Hu Z; Zhai X; Chen W; Wang S; Wang X; Qin J; Gao J; Liu J; Wang X; Wei Q; Shen H Int J Cancer; 2006 Nov; 119(9):2173-8. PubMed ID: 16804901 [TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of metastasis suppressor gene NME1 and breast cancer survival. Qu S; Long J; Cai Q; Shu XO; Cai H; Gao YT; Zheng W Clin Cancer Res; 2008 Aug; 14(15):4787-93. PubMed ID: 18676749 [TBL] [Abstract][Full Text] [Related]
13. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea. Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574 [TBL] [Abstract][Full Text] [Related]
14. A genome-wide association study of prognosis in breast cancer. Azzato EM; Pharoah PD; Harrington P; Easton DF; Greenberg D; Caporaso NE; Chanock SJ; Hoover RN; Thomas G; Hunter DJ; Kraft P Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1140-3. PubMed ID: 20332263 [TBL] [Abstract][Full Text] [Related]
15. Common single-nucleotide polymorphisms in DNA double-strand break repair genes and breast cancer risk. Pooley KA; Baynes C; Driver KE; Tyrer J; Azzato EM; Pharoah PD; Easton DF; Ponder BA; Dunning AM Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3482-9. PubMed ID: 19064565 [TBL] [Abstract][Full Text] [Related]
16. Association of cyclin D1 genotype with breast cancer risk and survival. Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481 [TBL] [Abstract][Full Text] [Related]
17. A single nucleotide polymorphism in the 3'untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. Kumar R; Smeds J; Berggren P; Straume O; Rozell BL; Akslen LA; Hemminki K Int J Cancer; 2001 Nov; 95(6):388-93. PubMed ID: 11668523 [TBL] [Abstract][Full Text] [Related]
18. Association of genetic polymorphisms in cell-cycle control genes and susceptibility to endometrial cancer among Chinese women. Cai H; Xiang YB; Qu S; Long J; Cai Q; Gao J; Zheng W; Shu XO Am J Epidemiol; 2011 Jun; 173(11):1263-71. PubMed ID: 21454826 [TBL] [Abstract][Full Text] [Related]
19. The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer. Toomey S; Madden SF; Furney SJ; Fan Y; McCormack M; Stapleton C; Cremona M; Cavalleri GL; Milewska M; Elster N; Carr A; Fay J; Kay EW; Kennedy S; Crown J; Gallagher WM; Hennessy BT; Eustace AJ Oncotarget; 2016 Nov; 7(46):75518-75525. PubMed ID: 27776352 [TBL] [Abstract][Full Text] [Related]
20. Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer. Knechtel G; Hofmann G; Gerger A; Renner W; Langsenlehner T; Szkandera J; Wolf G; Samonigg H; Krippl P; Langsenlehner U J Cancer Res Clin Oncol; 2010 Dec; 136(12):1813-9. PubMed ID: 20204402 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]